Status Epilepticus
📧 Sign up to get email alerts when something new happens for Status Epilepticus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-05-14Clinical Trial Update: To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE) [Phase 3]
A Phase 3 study evaluating intravenous ganaxolone added to standard of care for refractory status epilepticus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-07Clinical Trial Update: Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE) [Phase 2]
The Phase 2 trial evaluating IV ganaxolone as adjuvant therapy for established status epilepticus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-05-21Clinical Trial Update: Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus [Phase 2, Phase 3]
Clinical trial investigating ketamine infusion vs traditional anti-epileptic agents in refractory status epilepticus was withdrawn from phas…
-
CLINICAL_TRIALS withdrawal · 2017-08-29Clinical Trial Update: Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus [Phase 3]
Phase 3 trial evaluating adjunctive levetiracetam, lacosamide, and ketamine for refractory status epilepticus has been withdrawn.